Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study

BackgroundUlcerative colitis (UC) is a long-term condition marked by recurrent episodes of inflammation affecting the colonic mucosa. Despite mesalamine’s or 5-amino salicylic acid’s (5-ASA) established role in inducing and maintaining remission, some patients experience persistent symptoms and infl...

Повний опис

Бібліографічні деталі

Автори:	Mohannad O. Khrieba, Furqan M. Abdulelah, Nada A. Alsaleh, Hayam Ali AlRasheed, Tarek I. Ahmed, Azza El-Sayed Mansy, Manal A. Hamouda, Eslam Habba, Nora Elshorbagi, Ahmed G. Abd Elhameed, Eman Hamza, Muhammed M. Salahuddin, Shereen A. Mourad, Marwa Kamal
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-10-01
Серія:	Frontiers in Pharmacology
Предмети:	atorvastatin crp esr IBDQ-32 SCCAI ulcerative colitis
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1690513/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!